Appia Bio

Research, Research, Biotechnology research
Founded in 2020
Los Angeles, California
http://www.appiabio.com
None

About Appia Bio

Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded in 2020, Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).

Company Metrics

  • Employees: 51-100
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 52M None
  • Last Funding: 52M None (None)
  • Funding Status: None

Technology Stack

Appia Bio actively uses None products in their tech stack.

Market Presence

Industries: Research, Research, Biotechnology research

Headquarters: Los Angeles, California